Resource Hub
Donate Now
Who we are
Our Strategy
Strategy Extension
GPEI Action Plan
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
The Virus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
Polio-Free Countries
What we do
Access to Vaccines
Containment
Environmental Safeguarding
Gender Mainstreaming
Polio Gender Champions
Integration
Outbreak Preparedness & Response
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Routine Immunization
Supplementary Immunization
Surveillance
Donors & Financing
Financial Resource Requirements
GPEI Budget 2026
GPEI Budget 2025
GPEI Budget 2024
2020-2025 outbreak budget monitoring
Expenditure Information
Historical Contributions
Innovative Financing
News
Media Centre
Take Action
Donate
Who we are
Our Strategy
Strategy Extension
GPEI Action Plan
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
The Virus
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
Polio-Free Countries
What we do
Access to Vaccines
Containment
Environmental Safeguarding
Gender Mainstreaming
Polio Gender Champions
Integration
Outbreak Preparedness & Response
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Routine Immunization
Supplementary Immunization
Surveillance
Donors & Financing
Financial Resource Requirements
GPEI Budget 2026
GPEI Budget 2025
GPEI Budget 2024
2020-2025 outbreak budget monitoring
Expenditure Information
Historical Contributions
Innovative Financing
News
Media Centre
Take Action
Donate
Choose the resource category and filter for results
Resources for Polio Eradicators
Containment
- Global Action Plan for Poliovirus Containment (GAP)
- Containment Certification Scheme (CCS)
- Potentially Infectious Material (PIM) guidance
- Exposure guidance
GPEI Tools, Protocols and Guidelines
- Polio Post-Certification Strategy
- Outbreak preparedness and response
- Vaccines and logistics
- Surveillance
- Supplementary Immunization Activities (SIA)
- Webinars and E-Learning
- Communication for Eradication Strategies
- Strategies
Policy & Reports
Access to Vaccines
Advisory Committee on Poliomyelitis Eradication
AFRO Reports
Annual Reports
Containment Advisory Group
Declarations and Resolutions
Expenditure Reports
Financial Reports
- Non-FRR Reports
GACVS sub-committee on novel OPV2 safety
Gender Mainstreaming
Global Certification Commission
Global Polio Laboratory Network Reports
IMB Reports
Polio and Climate Change
Polio Newsletter
Polio Oversight Board (POB) Documents
Polio Oversight Board (POB) Letters
Polio Oversight Board (POB) Meeting Minutes
Polio Partners Group
Regional Certification Commission
Reports to WHO Governing Bodies
Semi-Annual Status Reports
Technical Advisory Groups
TIMB Reports
WHO Weekly Epidemiological Record
Multimedia
Photos
Videos
Sort by
Newest First
Oldest First
Filter
Reset
Resources for Polio Eradicators
>>
Containment
>>
Potentially Infectious Material (PIM) guidance
Potentially Infectious Material (PIM) guidance
Web Annex A: Country- and area-specific poliovirus data
Poliovirus containment: guidance to minimize risk for facilities collecting, handling or storing materials potentially infectious for polioviruses, 2nd ed
Web Annex B: SOP for the identification, destruction or preparation for containment of poliovirus infectious or potentially infectious materials
Web Annex C: Form 1 – Facility reporting form
Web Annex D: Form 2 – Progress reporting form on preparations for poliovirus containment and completion of Phase I of GAPIII
